Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Shimunov

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|October 29, 2020
Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, David Shimunov, Jason G Newman, et al.
The Laryngoscope|June 2, 2021
Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORSRyan M Carey, Robert M Brody, David Shimunov, et al.
Journal of Neurotrauma|January 14, 2015
Eye tracking detects disconjugate eye movements associated with structural traumatic brain injury and concussionUzma Samadani, Robert Ritlop, Marleen Reyes, et al.
Oral Oncology|November 6, 2021
Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinomaJustin R Shinn, Ryan M Carey, Leila J Mady, et al.
Head & Neck|December 16, 2020
Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapyRyan M Carey, David Shimunov, Gregory S Weinstein, et al.
Head & Neck|June 8, 2021
Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomasHarman S Parhar, Gregory S Weinstein, Bert W O'Malley, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Oral Oncology|May 1, 2021
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgeryChristina M Yver, David Shimunov, Gregory S Weinstein, et al.
Head & Neck|June 25, 2021
Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgeryLova Sun, David Shimunov, Erik X Tan, et al.
Journal of the National Cancer Institute|March 12, 2025
Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancerMalay K Sannigrahi, Lovely Raghav, Dominick J Rich, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
JAMA Otolaryngology-- Head & Neck Surgery|October 29, 2020
Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, David Shimunov, Jason G Newman, et al.
The Laryngoscope|June 2, 2021
Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORSRyan M Carey, Robert M Brody, David Shimunov, et al.
Journal of Neurotrauma|January 14, 2015
Eye tracking detects disconjugate eye movements associated with structural traumatic brain injury and concussionUzma Samadani, Robert Ritlop, Marleen Reyes, et al.
Oral Oncology|November 6, 2021
Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinomaJustin R Shinn, Ryan M Carey, Leila J Mady, et al.
Head & Neck|December 16, 2020
Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapyRyan M Carey, David Shimunov, Gregory S Weinstein, et al.
Head & Neck|June 8, 2021
Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomasHarman S Parhar, Gregory S Weinstein, Bert W O'Malley, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Oral Oncology|May 1, 2021
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgeryChristina M Yver, David Shimunov, Gregory S Weinstein, et al.
Head & Neck|June 25, 2021
Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgeryLova Sun, David Shimunov, Erik X Tan, et al.
Journal of the National Cancer Institute|March 12, 2025
Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancerMalay K Sannigrahi, Lovely Raghav, Dominick J Rich, et al.
Pageof 3